Toxic epidermal necrolysis associated with pentazocine therapy and severe reversible renal failure.
D000082:Acetaminophen; D058186:Acute Kidney Injury / Q000139:chemically induced*; D001773:Blood Cells / Q000032:analysis; D001794:Blood Pressure; D002744:Chlorpheniramine; D003023:Cloxacillin / Q000627:therapeutic use; D011431:Dextropropoxyphene; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010423:Pentazocine / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D012769:Shock / Q000139:chemically induced; D013166:Spondylitis / Q000188:drug therapy; D013210:Staphylococcus / Q000302:isolation & purification; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014511:Uremia / Q000139:chemically induced; D014546:Urinary Catheterization
D000082:Acetaminophen; D002744:Chlorpheniramine; D011239:Prednisolone; D003023:Cloxacillin; D010423:Pentazocine; D011431:Dextropropoxyphene; D006854:Hydrocortisone